Example: Heart Attack
Clinical Trials on Adnexal Diseases
Total 2828 results
-
NCT01288599CompletedConditions: Ovarian Cyst
-
NCT03093675CompletedConditions: Adnexal Diseases; Uterine Diseases
-
NCT02630329CompletedConditions: Natural Orifice Endoscopic Surgery; Disease, Adnexal; Laparoscopic Surgery
-
NCT04037813Not yet recruitingConditions: Tubal Obstruction
-
NCT02618785CompletedConditions: Tubal Obstruction
-
NCT00092170CompletedConditions: Infections; Pelvic Infections
-
NCT04031664Not yet recruitingConditions: Pelvic Inflammatory Diseases
-
NCT04035785Not yet recruitingConditions: Pelvic Inflammatory Diseases
-
NCT03391440Unknown statusConditions: Pelvic Inflammatory Disease
-
NCT02972151Unknown statusConditions: Pelvic Inflammatory Disease
-
NCT02567812RecruitingConditions: Inflammatory Pelvic Disease
-
NCT03828994RecruitingConditions: Pelvic Inflammatory Disease
-
NCT04234945RecruitingConditions: Infertility, Female; Pelvic Inflammatory Disease
-
NCT03054402CompletedConditions: Pelvic Inflammatory Disease
-
NCT01799356CompletedConditions: Pelvic Inflammatory Disease
-
NCT01640379CompletedConditions: Pelvic Inflammatory Disease (PID)
-
NCT00783419CompletedConditions: Pelvic Inflammatory Disease
-
NCT01160640CompletedConditions: Pelvic Inflammatory Disease
-
NCT01299259CompletedConditions: Pelvic Inflammatory Disease
-
NCT00871494CompletedConditions: Pelvic Inflammatory Disease
-
NCT01241110CompletedConditions: Pelvic Inflammatory Disease
-
NCT00453349CompletedConditions: Pelvic Inflammatory Disease
-
NCT00683865CompletedConditions: Pelvic Inflammatory Disease
-
NCT01842100CompletedConditions: Induced Abortion; Postaboral Pelvic Inflammatory Disease; Sexually Transmitted Infections
-
NCT04556071RecruitingConditions: Ovarian Neoplasms; Fallopian Tube Neoplasms; Endocrine Gland Neoplasms; Neoplasms by Site; Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; Carcinoma, Ovarian Epithelial; Ovarian Diseases; Adnexal Diseases; Genital Diseases, Female; Endocrine System Diseases; Gonadal Disorders; Carcinoma; Bevacizumab; Enzyme Inhibitors; Antineoplastic Agents; Molecular Mechanisms of Pharmacological Action; Angiogenesis; BRCA1 Mutation; BRCA2 Mutation; Homologous Recombination Deficiency